MCGRAW BENJAMIN F III — SEC insider filings
SEC reporting owner CIK 1216994. 8 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-06-21 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AERIE PHARMACEUTICALS INC (AERI) | Director | 5 | — | — | 11 |
| Evommune, Inc. (EVMN) | Director | 3 | — | — | 6 |
Insider filings — MCGRAW BENJAMIN F III
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Evommune, Inc. (EVMN) | Disposition to issuer (D): 37,960 (derivative) · Grant/award (A): 37,960 (derivative) · Disposition to issuer (D): 15,673 (derivative) · Grant/award (A): 15,673 (derivative) | EDGAR |
| 2026-06-03 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 15,673 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 37,960 (derivative) @ $0 | EDGAR |
| 2022-11-21 | 4 | AERIE PHARMACEUTICALS INC (AERI) | Disposition to issuer (D): 41,984 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 102,412 (derivative) @ $3.66 · Disposition to issuer (D): 16,854 (derivative) @ $9.14 | EDGAR |
| 2022-06-13 | 4 | AERIE PHARMACEUTICALS INC (AERI) | Grant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | AERIE PHARMACEUTICALS INC (AERI) | Tax withholding (F): 10,324 @ $8.30 | EDGAR |
| 2021-09-22 | 4 | AERIE PHARMACEUTICALS INC (AERI) | Grant/award (A): 34,513 @ $0 · Grant/award (A): 102,412 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | AERIE PHARMACEUTICALS INC (AERI) | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1216994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs